Cargando…
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis
AMS in chronic lung disease can be challenging. Causal treatment of treatable traits may be the most successful AMS strategy for patients with any chronic pulmonary disease and should be brought into focus. https://bit.ly/3ptrmV8
Autores principales: | Rademacher, Jessica, Martin, Luise, Theloe, Anja, Stahl, Mirjam, Mall, Marcus A., Joean, Oana, Fuge, Jan, Hansen, Gesine, Welte, Tobias, Schütz, Katharina, Ringshausen, Felix C., Dittrich, Anna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463032/ https://www.ncbi.nlm.nih.gov/pubmed/37650087 http://dx.doi.org/10.1183/23120541.00356-2023 |
Ejemplares similares
-
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus
por: Simon, Susanne, et al.
Publicado: (2023) -
Clinical and Microbiological Effects of an Antimicrobial Stewardship Program in Urology—A Single Center Before-After Study
por: Joean, Oana, et al.
Publicado: (2022) -
Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
por: Kamp, Jan C., et al.
Publicado: (2021) -
C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
por: Pink, Isabell, et al.
Publicado: (2021) -
Computed Tomography in Adults with Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease: Typical Imaging Findings
por: Dettmer, Sabine, et al.
Publicado: (2021)